Home Biomarkers PT TEST

PT TEST

Blood clotting Biomarker

Sample Needed

Collection Type: Blood

Body System

Related System: Blood clotting

Overview

Prothrombin Time (PT) measures how long it takes blood plasma to clot by assessing the extrinsic and common coagulation pathways primarily clotting factors I (fibrinogen), II (prothrombin), V, VII and X. It's used to detect bleeding risk, monitor anticoagulant therapy (especially warfarin), and evaluate liver synthetic function or vitamin K status. Symptoms that prompt testing include easy bruising, prolonged bleeding after injury or surgery, nosebleeds, blood in urine/stool, or unexpected bleeding on anticoagulants. Newborns normally have prolonged PT due to immature liver; older adults and most genders have similar reference ranges, though pregnancy and acute illness can alter results.

People also test for

Test Preparation

No special preparation is required

Why Do I Need This Test

Profile: Blood clotting - Symptoms: Unexplained bleeding or bruising, peri‑operative screening, therapeutic monitoring of warfarin - Diagnoses/monitoring: Liver synthetic dysfunction, vitamin K deficiency, disseminated intravascular coagulation (DIC), malabsorption, anticoagulant effect - Causes of abnormal values: anticoagulant drugs, liver disease, vitamin K deficiency, DIC, certain antibiotics - Biological meaning: Prolonged PT = deficiency/dysfunction of extrinsic/common pathway factors → bleeding risk; shortened PT = rare, may reflect hypercoagulable state - Lifestyle/family: Excess alcohol, poor diet, broad‑spectrum antibiotics, herbal supplements, family history of bleeding disorders

Run our symptom checker to see if this test is right for you

Symptom Checker

Understanding Test Results

A PT longer than the upper limit (e.g., >13.5 sec) or an INR >1.2 indicates slowed clotting.
Mild prolongation (PT ~14–20 sec or INR ~1.3–2.0) may reflect early liver disease, moderate vitamin K deficiency, or the therapeutic effect of low-dose anticoagulation.
Marked prolongation (PT >20 sec or INR >2.0–3.0) signals significant bleeding risk, severe liver dysfunction, overdose of vitamin K antagonists, or DIC and usually requires urgent evaluation.
Extremely high INR (>4–5) carries a high risk of spontaneous bleeding and often needs reversal.
Short PT values (below ~11 sec or INR <0.8) are uncommon; they can be seen with heightened clotting tendency (e.g., pregnancy, oral contraceptives or acute‑phase reactions) and may suggest increased thrombosis risk.
Interpretation must consider medications, clinical context, and comparison with baseline values.

Normal Range

11-13.5 seconds OR INR 0.8-1.2

FAQs

Q: What is a PT test for?

A: A PT (prothrombin time) test measures how long blood takes to clot, assessing the extrinsic and common coagulation pathways. It’s used to evaluate bleeding or clotting disorders, detect liver disease or vitamin K deficiency, and screen before surgery. It’s also used to monitor anticoagulant therapy (especially warfarin) by calculating the International Normalized Ratio (INR) to guide dosing.

Q: What does a PT test show?

A: A prothrombin time (PT) test measures how long blood takes to clot by assessing the extrinsic and common coagulation pathways. It detects bleeding or clotting disorders, monitors anticoagulant (warfarin) therapy using the INR, and helps identify liver disease, vitamin K deficiency, or disseminated intravascular coagulation. Abnormal results guide further testing and treatment decisions.

Q: What if a PT test is positive?

A: If a pregnancy test is positive, book a GP or local antenatal service to confirm with a blood test and arrange an early ultrasound. Start 400 mcg folic acid daily, stop alcohol, tobacco and recreational drugs, and review current medications with your clinician. Discuss options and support services. Seek urgent care for severe abdominal pain, heavy bleeding, fainting or shoulder-tip pain (possible ectopic pregnancy).

Q: What is the difference between PT and aPTT?

A: PT (prothrombin time) assesses the extrinsic and common coagulation pathways—depends on factors VII, X, V, II and fibrinogen—uses tissue factor, is reported in seconds and as INR, and is used to monitor warfarin. aPTT (activated partial thromboplastin time) evaluates intrinsic and common pathways—factors XII, XI, IX, VIII, X, V, II and fibrinogen—uses a contact activator and monitors unfractionated heparin; prolongation suggests factor deficiency or inhibitor.

Q: What is the PT INR test price?

A: PT/INR testing costs vary by country and setting. In the UK it’s usually provided free through the NHS. In the United States out‑of‑pocket lab prices commonly range from about $20 to $75 (lower with insurance). In India typical private‑lab fees are roughly ₹150–₹700. Community clinics and point‑of‑care testing may charge different amounts.

Q: How to prepare for a PT test?

A: Prepare by following a progressive training plan targeting test events (run, push-ups, sit-ups, etc.), include interval and strength sessions, and practice full mock tests weekly. Prioritize sleep, balanced meals rich in carbs and protein, and hydrate well. Warm up thoroughly before tests, taper intensity 48–72 hours prior, use proper gear, and address injuries early. Practice breathing, pacing, visualization, and goal-setting.